• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Post-tuberculosis and postinfected bronchiectasis: data from global registries.

作者信息

Oscullo Grace, Martinez-García Miguel-Angel, Centis Rosella, D'Ambrosio Lia, Gómez-Olivas Jose Daniel, Migliori Giovanni Battista

机构信息

. Servicio de Neumología e Instituto de Investigación La Fe - IISLAFE - Hospital Universitario y Politécnico La Fe, Valencia, España.

. Centro de Investigación Biomédica en Red de Enfermedades Respiratorias, Instituto de Salud Carlos III, Madrid, España.

出版信息

J Bras Pneumol. 2025 Sep 8;51(3):e20250153. doi: 10.36416/1806-3756/e20250153.

DOI:10.36416/1806-3756/e20250153
PMID:40929486
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12401148/
Abstract
摘要

相似文献

1
Post-tuberculosis and postinfected bronchiectasis: data from global registries.肺结核后及感染后支气管扩张：来自全球登记处的数据。
J Bras Pneumol. 2025 Sep 8;51(3):e20250153. doi: 10.36416/1806-3756/e20250153.
2
First results from the international paediatric bronchiectasis registry (Child-BEAR-Net Registry) describing multicountry variations in childhood bronchiectasis and its management: a multicentre, cross-sectional study.
Lancet Respir Med. 2025 Aug;13(8):698-708. doi: 10.1016/S2213-2600(25)00089-X. Epub 2025 Jun 16.
3
Assessing 5-year follow-up of core outcome set uptake for Bronchiectasis and Hidradenitis Suppurativa: a review of trial registry entries.评估支气管扩张症和化脓性汗腺炎核心结局集应用的5年随访：试验注册条目综述
BMJ Open. 2025 Aug 18;15(8):e095190. doi: 10.1136/bmjopen-2024-095190.
4
Dual antibiotics for bronchiectasis.用于支气管扩张症的双重抗生素疗法
Cochrane Database Syst Rev. 2018 Jun 11;6(6):CD012514. doi: 10.1002/14651858.CD012514.pub2.
5
Intermittent prophylactic antibiotics for bronchiectasis.支气管扩张症的间歇性预防性抗生素治疗。
Cochrane Database Syst Rev. 2022 Jan 5;1(1):CD013254. doi: 10.1002/14651858.CD013254.pub2.
6
Use of inhaled corticosteroids in bronchiectasis: data from the European Bronchiectasis Registry (EMBARC).吸入性糖皮质激素在支气管扩张症中的应用：来自欧洲支气管扩张症注册研究（EMBARC）的数据。
Thorax. 2025 May 20;80(6):358-368. doi: 10.1136/thorax-2024-221825.
7
Inhaled hyperosmolar agents for bronchiectasis.用于支气管扩张症的吸入性高渗剂。
Cochrane Database Syst Rev. 2014 May 12;2014(5):CD002996. doi: 10.1002/14651858.CD002996.pub3.
8
Macrolide antibiotics for bronchiectasis.用于支气管扩张症的大环内酯类抗生素
Cochrane Database Syst Rev. 2018 Mar 15;3(3):CD012406. doi: 10.1002/14651858.CD012406.pub2.
9
Retrospective cross-sectional study on bronchiectasis in adult Aboriginal Australians: disease characteristics and comparison with ethnically diverse global bronchiectasis registry cohorts.澳大利亚成年原住民支气管扩张症的回顾性横断面研究：疾病特征及与全球不同种族支气管扩张症登记队列的比较
BMJ Open Respir Res. 2025 Jan 21;12(1):e002139. doi: 10.1136/bmjresp-2023-002139.
10
Interventions for bronchiectasis: an overview of Cochrane systematic reviews.支气管扩张症的干预措施：Cochrane系统评价概述
Cochrane Database Syst Rev. 2015 Jul 14;2015(7):CD010337. doi: 10.1002/14651858.CD010337.pub2.

本文引用的文献

1
COPD and bronchiectasis; more than mere enemies.慢性阻塞性肺疾病与支气管扩张症；不止是单纯的“敌人”。
J Bras Pneumol. 2025 Jun 13;51(2):e20250086. doi: 10.36416/1806-3756/e20250086.
2
Registries for bronchiectasis in the world: an opportunity for international collaboration.全球支气管扩张症登记处：国际合作的契机
Int J Tuberc Lung Dis. 2025 May 25;29(5):199-201. doi: 10.5588/ijtld.25.0157.
3
Pulmonary Rehabilitation in Patients With Post-Tuberculosis Lung Disease: A Prospective Multicentre Study.肺结核后肺部疾病患者的肺康复：一项前瞻性多中心研究
Arch Bronconeumol. 2025 Feb 22. doi: 10.1016/j.arbres.2025.02.007.
4
Lung function and health-related quality of life among adult patients following pulmonary TB treatment.肺结核治疗后成年患者的肺功能和健康相关生活质量。
Int J Tuberc Lung Dis. 2024 Sep 1;28(9):419-426. doi: 10.5588/ijtld.24.0029.
5
Post-TB bronchiectasis: clinical characteristics and microbiology.肺结核后支气管扩张：临床特征与微生物学
Int J Tuberc Lung Dis. 2024 Aug 1;28(8):405-406. doi: 10.5588/ijtld.24.0151.
6
Mortality Risk in Bronchiectasis.支气管扩张症的死亡风险
Arch Bronconeumol. 2024 Jun;60(6):333-335. doi: 10.1016/j.arbres.2024.04.006. Epub 2024 Apr 24.
7
A new understanding of clinical patterns in post-TB lung disease.对肺结核后肺部疾病临床模式的新认识。
Int J Tuberc Lung Dis. 2024 Mar 1;28(3):115-121. doi: 10.5588/ijtld.23.0327.
8
Idiopathic bronchiectasis. What are we talking about?特发性支气管扩张症。我们在讨论什么？
J Bras Pneumol. 2023 Nov 17;49(5):e20230249. doi: 10.36416/1806-3756/e20230249.
9
Bronchiectasis: Changes in the Characterization of Patients During 20 Years of Follow-up. Data from the Spanish Bronchiectasis Registries.支气管扩张症：20年随访期间患者特征的变化。来自西班牙支气管扩张症登记处的数据。
Arch Bronconeumol. 2023 Oct;59(10):688-690. doi: 10.1016/j.arbres.2023.07.023. Epub 2023 Jul 27.
10
Dual Broncodilator and Triple Therapy in Bronchiectasis. Clinical Trials are Urgently Needed.
Arch Bronconeumol. 2023 Dec;59(12):787-788. doi: 10.1016/j.arbres.2023.07.013. Epub 2023 Jul 22.